Serum leptin and adiponectin levels and risk of renal cell carcinoma

The incidence of renal cell carcinoma (RCC) has increased rapidly in the U.S., particularly among African Americans. Despite a well‐established link between obesity and RCC, the mechanism through which obesity increases cancer risk has yet to be established. Adipokines, such as leptin and adiponectin, may link obesity and cancer, with different quantitative effects by race.

• Publication year

  2012

• Venue

  Obesity

• Publication date

  2012-11-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/oby.20138PMID 23666639PMCID 3742622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in the Association between Serum Leptin Levels and Body Mass Index in Black and White Women: A Report from the Southern Community Cohort Study

  2012cited by this paper
• Hypertension and Risk of Renal Cell Carcinoma Among White and Black Americans

  2011cited by this paper
• Serum adiponectin in relation to body mass index and other correlates in black and white women.

  2011cited by this paper
• Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC).

  2010cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2008.

  2010cited by this paper
• Variants in the Adiponectin Gene and Serum Adiponectin: The Coronary Artery Development in Young Adults (CARDIA) Study

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Epidemiology and risk factors for kidney cancer

  2010cited by this paper
• Insulin resistance in African-American and Caucasian women: differences in lipotoxicity, adipokines, and gene expression in adipose tissue and muscle.

  2010cited by this paper
• Re: Jehonathan H. Pinthus, Nir Kleinmann, Britton Tisdale, et al. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol 2008;54:866-74.

  2009cited by this paper
• Inverse association of leptin levels with renal cell carcinoma: Results from a case-control study

  2009cited by this paper
• Obesity and cancer: Pathophysiological and biological mechanisms

  2008cited by this paper
• Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells

  2008cited by this paper
• Body size and renal cell cancer incidence in a large US cohort study.

  2008cited by this paper
• Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.

  2008cited by this paper
• Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

  2008cited by this paper
• Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival.

  2008cited by this paper
• Low adiponectin levels are associated with renal cell carcinoma: A case‐control study

  2007cited by this paper
• Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

  2007cited by this paper
• Endocrinology of Adipose Tissue - An Update

  2007cited by this paper
• Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.

  2007cited by this paper
• Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States).

  2007cited by this paper
• Adipocytokines: mediators linking adipose tissue, inflammation and immunity

  2006cited by this paper
• Adipocytokines and cancer.

  2006cited by this paper
• Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway.

  2006cited by this paper
• Leptin and cancer

  2006cited by this paper
• Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma.

  2006cited by this paper
• Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.

  2005cited by this paper
• Adiponectin and adiponectin receptors.

  2005cited by this paper
• Epidemiology and risk factors of kidney cancer.

  2004cited by this paper
• Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

  2004cited by this paper
• Circulating adiponectin and endometrial cancer risk.

  2004cited by this paper
• Adiponectin and breast cancer risk.

  2004cited by this paper
• Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex

  2003cited by this paper
• Association of serum adiponectin levels with breast cancer risk.

  2003cited by this paper
• Racial disparity in incidence patterns and outcome of kidney cancer.

  2003cited by this paper
• Leptin concentrations in the United States: relations with demographic and anthropometric measures.

  2001cited by this paper
• Obesity, hypertension, and the risk of kidney cancer in men.

  2000cited by this paper
• Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

  1999cited by this paper
• Rising incidence of renal cell cancer in the United States.

  1999cited by this paper
• Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

  1996cited by this paper
• Cancer statistics

  1989cited by this paper
• Concepts of interaction.

  1980cited by this paper

• The Role of Perirenal Adipose Tissue in Carcinogenesis—From Molecular Mechanism to Therapeutic Perspectives

  2025cites this paper
• Unveiling the perfect workout: exercise modalities and dosages to ameliorate adipokine dysregulation in individuals with overweight and obesity: a systematic review with pairwise, network, and dose–response meta-analyses

  2025cites this paper
• Obesity as a Systems-Level Driver of Cancer: Mechanisms and Nutritional Reprogramming.

  2025cites this paper
• A review of biological function of the explored and unexplored adipokines from normal to cancerous kidney

  2025cites this paper
• Research progress on the correlation between obesity and the occurrence and development of kidney cancer: a narrative review

  2024cites this paper
• Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?

  2024cites this paper
• Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression

  2024cites this paper
• Adiposity and cancer: systematic review and meta-analysis

  2024cites this paper
• Impact of Two Types of Exercise Interventions on Leptin and Omentin Concentrations and Indicators of Lipid and Carbohydrate Metabolism in Males with Metabolic Syndrome

  2023cites this paper
• Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact

  2023cites this paper
• Lifetime body weight trajectories and risk of renal cell cancer: a large US prospective cohort study.

  2023cites this paper
• Pathophysiology of obesity and its associated diseases

  2023cites this paper
• Role of insulin-like growth factor, pro-inflammatory and anti-inflammatory cytokines, transcription factors and adipokines in development of hepatocellular carcinoma in metabolic syndrome

  2022cites this paper
• Plasma concentration of Bisphenol A and leptin in patients with meningioma and glioma: A pilot study.

  2022cites this paper
• Digital Scholarship @ Texas Southern University Digital Scholarship @ Texas Southern University

  2022cites this paper
• Understanding the link between kidney stones and cancers of the upper urinary tract and bladder.

  2022cites this paper
• Vitexin, a fenugreek glycoside, ameliorated obesity-induced diabetic nephropathy via modulation of NF-κB/IkBα and AMPK/ACC pathways in mice.

  2021cites this paper
• Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value

  2021cites this paper
• Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Leptin, Both Bad and Good Actor in Cancer

  2021cites this paper
• Metabolic pathways in sporadic colorectal carcinogenesis: A new proposal.

  2021cites this paper
• A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma

  2020cites this paper
• Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: A meta-analysis

  2020cites this paper
• Hormone Effects on Tumors

  2020cites this paper
• Circulating adipokine concentrations and risk of five obesity‐related cancers: A Mendelian randomization study

  2020cites this paper
• The Role of Metabolic Factors in Renal Cancers

  2020cites this paper
• Epidemiology of Renal Cell Carcinoma

  2020cites this paper
• Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease

  2019cites this paper
• A novel leptin receptor antagonist uncouples leptin’s metabolic and immune functions

  2019cites this paper
• Systematic review of modifiable risk factors for kidney cancer.

  2019cites this paper
• Prognostic biomarkers in renal cell carcinoma: is there a relationship with obesity?

  2019influential citation
• Complex interaction of adiponectin-mediated pathways on cancer treatment: a novel therapeutic target

  2019influential citation
• Circulating obesity-driven biomarkers are associated with risk of clear cell renal cell carcinoma: a two-stage, case-control study.

  2019cites this paper
• Circulating adipokines and risk of obesity related cancers: A systematic review and meta-analysis.

  2019cites this paper
• Altered circulating levels of adipokine omentin-1 in patients with prostate cancer

  2019cites this paper
• Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.

  2019influential citation
• Perioperative Management of the Genitourinary Oncologic Patient Undergoing Partial/Radical Nephrectomy

  2019cites this paper
• Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis

  2019influential citation
• The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

  2019cites this paper
• OTT_A_197507 3313..3319

  2019cites this paper
• Analysis of inflammatory markers and hormones in old cancer patients: A descriptive study.

  2019cites this paper
• DISTURBED SERUM LEVELS OF ADIPOCYTOKINES , INSULIN RESISTANCE AND GYNECOLOGICAL NEOPLASTIC LESIONS : A TRIANGLE OF DANGER By

  2018cites this paper
• Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?

  2018cites this paper
• Circulating levels of adiponectin and leptin in patients with prostate cancer

  2018cites this paper
• Association between leptin level and renal cell carcinoma susceptibility and progression: A meta-analysis

  2018cites this paper
• Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma.

  2017cites this paper
• Leptin in Cancer: Epidemiology and Mechanisms

  2017cites this paper
• Epidemiology of Renal Cell Carcinoma

  2017cites this paper
• The Leptin Receptor Complex: Heavier Than Expected?

  2017cites this paper
• Title Adiponectin-based Therapeutics in Cancer Treatment

  2017cites this paper
• Adiponectin-Based Therapeutics for Cancer Treatment

  2017cites this paper
• Systematic Review and Meta-Analysis of Randomized, Controlled Trials on the Effect of Exercise on Serum Leptin and Adiponectin in Overweight and Obese Individuals

  2017cites this paper
• Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial

  2017cites this paper
• The Function and Diagnostic Potential of Adipocyte-Derived Factors in the Tumor Microenvironment

  2017cites this paper
• Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer.

  2016cites this paper
• Circulating levels of adipocytokines omentin-1 and adiponectin in patients with bladder cancer

  2016cites this paper
• Evolving role of adiponectin in cancer-controversies and update

  2016cites this paper
• Obesity and Kidney Cancer.

  2016cites this paper
• Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals.

  2016cites this paper
• Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma

  2016cites this paper
• Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies

  2016influential citation
• ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma

  2015cites this paper
• Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity

  2015cites this paper
• Serum leptin, C‐reactive protein, and cancer mortality in the NHANES III

  2015cites this paper
• Prediction of Perioperative Death Following Surgery for Renal Cell Carcinoma with Vein Involvement: A Retrospective Study

  2015cites this paper
• Adipokiinit ja YKL-40 munuaissyövässä

  2015cites this paper
• Obesity, adipokines and cancer: an update

  2015cites this paper
• Leptin: From structural insights to the design of antagonists.

  2015cites this paper
• Antagonizing leptin: current status and future directions

  2014cites this paper
• New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases

  2014cites this paper
• Obesity and renal cancer

  2014influential citation
• Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?

  2014cites this paper
• Der Einfluss von Adipositas auf urologische Tumorerkrankungen

  2013cites this paper
• For Peer Review Pre-diagnostic Circulating Adipokine Concentrations and Risk of Renal Cell Carcinoma

  2012cites this paper